Phase 2 SCLC, Limited Stage Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

SCLC, Limited Stage

Guangdong Provincial People's Hospital45 enrolled1 locationNCT06911606

Recruiting

Phase 2

Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)

SCLC, Limited Stage

Hebei Medical University Fourth Hospital58 enrolled1 locationNCT06371482